glp-1 agonists for type 2 diabetes receptor are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 Receptor Agonists: The New
Description
Exercise has been shown to synergize with ketogenic diets and intermittent fasting by further improving insulin sensitivity, promoting fat loss, and preserving lean muscle mass
If you listen to this podcast and do it the way we talk about it
Additionally, GLP-1RA is also recommended for patients with T2DM at risk of with heart failure
Motility and Metabolic Pharmacoepidemiology Group, Ma KS, et al
Aging is a crucial component of the pathogenesis of CVD, as reflected by increased oxidative stress and impaired antioxidant defense, responses which may be induced by psychosocial stress [122, 148]
Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting
